Dynamic Neutrophil-to-Lymphocyte Ratio: A Novel Prognosis Measure for Triple-Negative Breast Cancer

被引：0
|
作者：
Dan Moldoveanu
Vera Pravongviengkham
Gordie Best
Constanza Martínez
Tarek Hijal
Ari Nareg Meguerditchian
Mathieu Lajoie
Sinziana Dumitra
Ian Watson
Sarkis Meterissian
机构：
[1] McGill University Health Centre,
来源：
Annals of Surgical Oncology | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4028 / 4034
页数：6
相关论文
共 50 条
  • [31] Predictive role of derived neutrophil to lymphocyte ratio on platinum-based chemotherapy in triple-negative breast cancer
    Marra, A.
    Viale, G.
    Trapani, D.
    Nicolo, E.
    Morganti, S.
    Esposito, A.
    Minchella, I.
    Criscitiello, C.
    Curigliano, G.
    Locatelli, M. A.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [32] Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer
    Pang, Jian
    Zhou, Haiyan
    Dong, Xue
    Wang, Shouman
    Xiao, Zhi
    [J]. CLINICAL BREAST CANCER, 2021, 21 (06) : E681 - E687
  • [33] Neutrophil-to-lymphocyte ratio as an indicator of prognosis in patients with pancreatic cancer
    Kawada, Tomoyuki
    [J]. HPB, 2019, 21 (12) : 1791 - 1791
  • [34] Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer
    He, Juanjuan
    Lv, Pengwei
    Yang, Xue
    Chen, Yanli
    Liu, Chao
    Qiu, Xinguang
    [J]. TUMOR BIOLOGY, 2016, 37 (07) : 9037 - 9043
  • [35] Elevated neutrophil to lymphocyte ratio to predict survival outcome after recurrence for patients with triple-negative breast cancer.
    Iwase, Toshiaki
    Sangai, Takafumi
    Sakakibara, Masahiro
    Nagashima, Takeshi
    Miyazaki, Masaru
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [36] Prognostic Roles of Neutrophil-to-Lymphocyte Ratio and Stromal Tumor-Infiltrating Lymphocytes and Their Relationship in Locally Advanced Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy
    Dong, Xue
    Liu, Congfang
    Yuan, Jiaqi
    Wang, Shouman
    Ding, Nianhua
    Li, Yong
    Wu, Yuhui
    Xiao, Zhi
    [J]. BREAST CARE, 2021, 16 (04) : 328 - 334
  • [37] Usefulness of the pre-treatment neutrophil-to-lymphocyte ratio in predicting first-line progression free-survival in triple-negative breast cancer patients
    Fontanella, C.
    Fanotto, V.
    Gerratana, L.
    Bonotto, M.
    Cinausero, M.
    Bozza, C.
    Iacono, D.
    Russo, S.
    Andreetta, C.
    Minisini, A. M.
    Moroso, S.
    Mansutti, M.
    Fasola, G.
    Puglisi, F.
    [J]. CANCER RESEARCH, 2016, 76
  • [38] Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?
    Ahmet Dirican
    Betul Bolat Kucukzeybek
    Ahmet Alacacioglu
    Yuksel Kucukzeybek
    Cigdem Erten
    Umut Varol
    Isil Somali
    Lutfiye Demir
    Ibrahim Vedat Bayoglu
    Yasar Yildiz
    Murat Akyol
    Betul Koyuncu
    Eyup Coban
    Eda Ulger
    Fulya Cakalagaoglu Unay
    Mustafa Oktay Tarhan
    [J]. International Journal of Clinical Oncology, 2015, 20 : 70 - 81
  • [39] Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?
    Dirican, Ahmet
    Kucukzeybek, Betul Bolat
    Alacacioglu, Ahmet
    Kucukzeybek, Yuksel
    Erten, Cigdem
    Varol, Umut
    Somali, Isil
    Demir, Lutfiye
    Bayoglu, Ibrahim Vedat
    Yildiz, Yasar
    Akyol, Murat
    Koyuncu, Betul
    Coban, Eyup
    Ulger, Eda
    Unay, Fulya Cakalagaoglu
    Tarhan, Mustafa Oktay
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (01) : 70 - 81
  • [40] Prognostic Value of the Neutrophil-Lymphocyte Ratio in Triple Negative Breast Cancer Patients
    Shi, Kate
    Westhuyzen, Justin
    Gortman, Aron
    Shakespeare, Thomas P.
    Aherne, Noel J.
    [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2022, 52 (01): : 33 - 39
12345